Draft:Robin Fross
| Submission declined on 28 January 2024 by Greenman (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 27 January 2024 by Theroadislong (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. | |
Comment: Very little improvement since previous decline? Theroadislong (talk) 17:45, 27 January 2024 (UTC)
 | This article is an autobiography or has been extensively edited by the subject or by someone connected to the subject. (January 2024) |
Robin Fross, M.D., F.A.A.N. is a neurologist specializing in the diagnosis and treatment of Parkinson’s disease and other movement disorders (1987-2018). She was also an associate clinical professor of neurology at the University of California - San Francisco (U.C.S.F.). She directed the first botulinum toxin (Botox) clinic for neurologic disorders in Northern California while at Kaiser-Permanente. She also was instrumental in starting the first Neuroscience Movement Disorders Program in Northern California providing stereotactic neurosurgical treatment for Parkinson’s disease and other movement disorders, while at Kaiser.
Education and Career[edit]
She received her medical degree from the Medical College of Wisconsin in 1979, then pursued internal medicine training at Evanston Hospital - Northwestern University, until changing fields in 1982 to receive her neurology residency training at the Mayo Clinic in Rochester, Minnesota (1982-1985), followed by a clinical fellowship in the subspeciality of Movement Disorders at the University of British Columbia in Vancouver, B.C. (1985-1987).
She spent her 30-year clinical career at Northern California Kaiser-Permanente, with additional time as consultant at the Parkinson’s Institute in Sunnyvale, California (1991-1994) and at the Sonoma Developmental Center in Eldridge, California (1990-1994). In addition, she taught neurology residents-in-training in their outpatient clinics at U.C.S.F. (1994-2018), retiring as an associate clinical professor of neurology.
During her fellowship from 1985-1987, before botulinum toxin (Botox) was approved for clinical use by the FDA, she participated in clinical trials of the drug’s use in treating the movement disorder “spasmodic torticollis” (cervical dystonia) [1]. Immediately upon approval of botulinum toxin by the FDA for clinical use in treating eye disorders (strabismus and blepharospasm) in 1990, she began to use the drug in off-label (and later FDA approved) treatment of cervical dystonia and other movement disorders [2], starting the first Northern California clinic for botulinum toxin treatment of dystonia and movement disorders.
In 1994, along with colleague neurologists Helen Bronte-Stewart and Jeff Klingman at Kaiser-Permanente [3], she put together the first comprehensive neuroscience program for Parkinson’s disease and other movement disorders to provide stereotactic neurosurgical treatment (brain surgery) in carefully evaluated and qualified patients, including use of internationally developed protocols and extensive (lifelong) followup management [4]. The first patients to receive stereotactic surgery in the program happened in 1996. Dr Bronte-Stewart went on to develop the Stanford Movement Disorders Center shortly thereafter.
Honors[edit]
Dr Fross was elected a Fellow of the American Academy of Neurology in 1996.
Personal Life[edit]
Dr Fross is the granddaughter of Hank Mann, silent film comedian (an original Keystone cop and in several Charlie Chaplin films).
References[edit]
1) Tsui, J, Fross, R, Calne, S, Calne, D. Local treatment of spasmodic torticollis with botulinum toxin. Can. J. Neurol. Sci.14(3, Suppl.):533-5, 1987.
2) Fross, RD. Bruxism and masticatory myalgias: Use of botulinum toxin. Movement Disorders 15 (Suppl.2):35, 2000.
3) Fross, R, Brontë-Stewart, H, Klingman, J. The New Dopamine Agonists in Practice: Initial Experience in a Large Parkinson’s Disease Clinic. Movement Disorders 14(4):S3.168,1998
4) Brontë-Stewart, H, Hill, B, Pappas, C, Fross, R, et al. Lesion Location Predicts Outcome of Ventrolateral Pallidotomy in Parkinson's Disease. Movement Disorders 14(4):S6.080, 1998
5) https://www.researchgate.net/scientific-contributions/Robin-D-Fross-39545139